Medical isotope firm Shine Medical Technologies has raised $150 million in a new round of financing.
The Series C-5 financing round was led by Koch Disruptive Technologies and included participation by Fidelity Management & Research Company, Baillie Gifford, and other new and current investors, according to Shine. The company said it would use the funds to support commercialization of its diagnostic and therapeutic medical isotope technologies, as well as development of new fusion-based technology applications.
